Historical Valuation
Repligen Corp (RGEN) is now in the Fair zone, suggesting that its current forward PE ratio of 85.23 is considered Fairly compared with the five-year average of 83.67. The fair price of Repligen Corp (RGEN) is between 114.43 to 174.79 according to relative valuation methord.
Relative Value
Fair Zone
114.43-174.79
Current Price：166.42
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Repligen Corp (RGEN) has a current Price-to-Book (P/B) ratio of 4.44. Compared to its 3-year average P/B ratio of 4.33 , the current P/B ratio is approximately 2.60% higher. Relative to its 5-year average P/B ratio of 5.33, the current P/B ratio is about -16.71% higher. Repligen Corp (RGEN) has a Forward Free Cash Flow (FCF) yield of approximately 1.19%. Compared to its 3-year average FCF yield of 1.26%, the current FCF yield is approximately -5.65% lower. Relative to its 5-year average FCF yield of 0.92% , the current FCF yield is about 29.06% lower.
P/B
Median3y
4.33
Median5y
5.33
FCF Yield
Median3y
1.26
Median5y
0.92
Competitors Valuation Multiple
AI Analysis for RGEN
The average P/S ratio for RGEN competitors is 1577.93, providing a benchmark for relative valuation. Repligen Corp Corp (RGEN.O) exhibits a P/S ratio of 11.59, which is -99.27% above the industry average. Given its robust revenue growth of 21.91%, this premium appears sustainable.
Performance Decomposition
AI Analysis for RGEN
1Y
3Y
5Y
Market capitalization of RGEN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of RGEN in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is RGEN currently overvalued or undervalued?
Repligen Corp (RGEN) is now in the Fair zone, suggesting that its current forward PE ratio of 85.23 is considered Fairly compared with the five-year average of 83.67. The fair price of Repligen Corp (RGEN) is between 114.43 to 174.79 according to relative valuation methord.
What is Repligen Corp (RGEN) fair value?
RGEN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Repligen Corp (RGEN) is between 114.43 to 174.79 according to relative valuation methord.
How does RGEN's valuation metrics compare to the industry average?
The average P/S ratio for RGEN's competitors is 1577.93, providing a benchmark for relative valuation. Repligen Corp Corp (RGEN) exhibits a P/S ratio of 11.59, which is -99.27% above the industry average. Given its robust revenue growth of 21.91%, this premium appears sustainable.
What is the current P/B ratio for Repligen Corp (RGEN) as of Jan 09 2026?
As of Jan 09 2026, Repligen Corp (RGEN) has a P/B ratio of 4.44. This indicates that the market values RGEN at 4.44 times its book value.
What is the current FCF Yield for Repligen Corp (RGEN) as of Jan 09 2026?
As of Jan 09 2026, Repligen Corp (RGEN) has a FCF Yield of 1.19%. This means that for every dollar of Repligen Corp’s market capitalization, the company generates 1.19 cents in free cash flow.
What is the current Forward P/E ratio for Repligen Corp (RGEN) as of Jan 09 2026?
As of Jan 09 2026, Repligen Corp (RGEN) has a Forward P/E ratio of 85.23. This means the market is willing to pay $85.23 for every dollar of Repligen Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Repligen Corp (RGEN) as of Jan 09 2026?
As of Jan 09 2026, Repligen Corp (RGEN) has a Forward P/S ratio of 11.59. This means the market is valuing RGEN at $11.59 for every dollar of expected revenue over the next 12 months.